STOK
$24.17-1.79%
Stoke Therapeutics Inc.Stock · HealthcareRussell 2000 0.06%Nasdaq Composite 0.005%US Stock Market 0.003%Russell 3000 0.002%
Stoke Therapeutics Inc. monthly returns
Stoke Therapeutics Inc. has averaged 1.94% per month, positive in 46% of months. Month-by-month returns for Stoke Therapeutics Inc. (STOK) below, through October 16, 2026 — the table lists the most recent months; the bar chart plots the last 5 years.
Average month
+1.9%
82 months
Best month
+74.4%
Mar 2024
Worst month
-49.2%
Nov 2022
Positive months
46%
of all months
Stoke Therapeutics Inc. monthly returns#
| Month | Path | Total return |
|---|---|---|
| Oct 2026 | -7.0% | |
| Sep 2026 | -16.7% | |
| Aug 2026 | +8.1% | |
| Jul 2026 | -11.8% | |
| Jun 2026 | +5.9% | |
| May 2026 | -5.5% | |
| Apr 2026 | +0.5% | |
| Mar 2026 | -10.6% | |
| Feb 2026 | +20.0% | |
| Jan 2026 | -4.4% | |
| Dec 2025 | +2.7% | |
| Nov 2025 | +2.9% | |
| Oct 2025 | +27.8% | |
| Sep 2025 | +18.9% | |
| Aug 2025 | +53.8% | |
| Jul 2025 | +13.2% | |
| Jun 2025 | +19.0% | |
| May 2025 | -2.3% | |
| Apr 2025 | +46.8% | |
| Mar 2025 | -15.3% | |
| Feb 2025 | -31.6% | |
| Jan 2025 | +4.1% | |
| Dec 2024 | -8.9% | |
| Nov 2024 | -2.0% | |
| Oct 2024 | +0.6% | |
| Sep 2024 | -15.5% | |
| Aug 2024 | -2.8% | |
| Jul 2024 | +10.8% | |
| Jun 2024 | -7.6% | |
| May 2024 | +32.5% | |
| Apr 2024 | -18.3% | |
| Mar 2024 | +74.4% | |
| Feb 2024 | +59.9% | |
| Jan 2024 | -8.0% | |
| Dec 2023 | +38.8% | |
| Nov 2023 | -0.5% | |
| Oct 2023 | -3.3% | |
| Sep 2023 | -29.9% | |
| Aug 2023 | -15.4% | |
| Jul 2023 | -37.5% | |
| Jun 2023 | -5.1% | |
| May 2023 | +26.0% | |
| Apr 2023 | +6.7% | |
| Mar 2023 | -6.3% | |
| Feb 2023 | -10.7% | |
| Jan 2023 | +7.9% | |
| Dec 2022 | +22.4% | |
| Nov 2022 | -49.2% | |
| Oct 2022 | +15.7% | |
| Sep 2022 | -14.7% | |
| Aug 2022 | +1.8% | |
| Jul 2022 | +12.0% | |
| Jun 2022 | +9.1% | |
| May 2022 | -16.1% | |
| Apr 2022 | -31.4% | |
| Mar 2022 | +7.9% | |
| Feb 2022 | +2.9% | |
| Jan 2022 | -21.0% | |
| Dec 2021 | -3.7% | |
| Nov 2021 | +9.1% | |
| Oct 2021 | -10.3% | |
| Sep 2021 | -2.8% | |
| Aug 2021 | -8.6% | |
| Jul 2021 | -14.9% | |
| Jun 2021 | -15.1% | |
| May 2021 | +22.8% | |
| Apr 2021 | -16.8% | |
| Mar 2021 | -35.1% | |
| Feb 2021 | -1.9% | |
| Jan 2021 | -1.4% | |
| Dec 2020 | +18.9% | |
| Nov 2020 | +35.7% | |
| Oct 2020 | +14.6% | |
| Sep 2020 | +14.0% | |
| Aug 2020 | +16.6% | |
| Jul 2020 | +5.7% | |
| Jun 2020 | -13.8% | |
| May 2020 | +31.5% | |
| Apr 2020 | -8.2% | |
| Mar 2020 | -7.5% | |
| Feb 2020 | -11.5% | |
| Jan 2020 | -1.3% | |
| Dec 2019 | +15.6% | |
| Nov 2019 | -13.5% | |
| Oct 2019 | +31.9% | |
| Sep 2019 | -42.6% | |
| Aug 2019 | +51.9% | |
| Jul 2019 | -15.5% |
Monthly total return (since Nov 2021)#
-60%-40%-20%0%20%40%60%
Nov 2021+9.1%
Dec 2021-3.7%
Jan 2022-21%2022
Feb 2022+2.9%
Mar 2022+7.9%
Apr 2022-31%
May 2022-16%
Jun 2022+9.1%
Jul 2022+12%
Aug 2022+1.8%
Sep 2022-15%
Oct 2022+16%
Nov 2022-49%
Dec 2022+22%
Jan 2023+7.9%2023
Feb 2023-11%
Mar 2023-6.3%
Apr 2023+6.7%
May 2023+26%
Jun 2023-5.1%
Jul 2023-38%
Aug 2023-15%
Sep 2023-30%
Oct 2023-3.3%
Nov 2023-0.52%
Dec 2023+39%
Jan 2024-8.0%2024
Feb 2024+60%
Mar 2024+74%
Apr 2024-18%
May 2024+33%
Jun 2024-7.6%
Jul 2024+11%
Aug 2024-2.8%
Sep 2024-16%
Oct 2024+0.57%
Nov 2024-2.0%
Dec 2024-8.9%
Jan 2025+4.1%2025
Feb 2025-32%
Mar 2025-15%
Apr 2025+47%
May 2025-2.3%
Jun 2025+19%
Jul 2025+13%
Aug 2025+54%
Sep 2025+19%
Oct 2025+28%
Nov 2025+2.9%
Dec 2025+2.7%
Jan 2026-4.4%2026
Feb 2026+20%
Mar 2026-11%
Apr 2026+0.49%
May 2026-5.5%
Jun 2026+5.9%
Jul 2026-12%
Aug 2026+8.1%
Sep 2026-17%
Oct 2026-7.0%
Stoke Therapeutics Inc. returns by calendar month#
Every month of every year since 2020, one tick per year on a shared scale; the dark bar is the month's average. Total returns, dividends reinvested.
October 2026 so far: -7.04% — 6th of 7 Octobers since 2020 at the last close; the average October returned +7.5%.
| Month | −75%0+75% | Average | Median | Up | Best | Worst |
|---|---|---|---|---|---|---|
| Jan | -3.4% | -1.4% | 29% | +7.9% 2023 | -21.0% 2022 | |
| Feb | +3.9% | -1.9% | 43% | +59.9% 2024 | -31.6% 2025 | |
| Mar | +1.1% | -7.5% | 29% | +74.4% 2024 | -35.1% 2021 | |
| Apr | -3.0% | -8.2% | 43% | +46.8% 2025 | -31.4% 2022 | |
| May | +12.7% | +22.8% | 57% | +32.5% 2024 | -16.1% 2022 | |
| Jun | -1.1% | -5.1% | 43% | +19.0% 2025 | -15.1% 2021 | |
| Jul | -3.2% | +5.7% | 57% | +13.2% 2025 | -37.5% 2023 | |
| Aug | +7.7% | +1.8% | 57% | +53.8% 2025 | -15.4% 2023 | |
| Sep | -6.7% | -14.7% | 29% | +18.9% 2025 | -29.9% 2023 | |
| Oct | +7.5% | +7.6% | 67% | +27.8% 2025 | -10.3% 2021 | |
| Nov | -0.7% | +1.2% | 50% | +35.7% 2020 | -49.2% 2022 | |
| Dec | +11.7% | +10.8% | 67% | +38.8% 2023 | -8.9% 2024 |
Methodology#
Monthly returns are total returns (dividends reinvested), computed from STOK's split- and dividend-adjusted month-end closes. The table shows the most recent 120 months and the bar chart the most recent 60. See the year-by-year returns for the annual view. Past performance does not predict future returns; not investment advice.
FAQ#
- What is Stoke Therapeutics Inc.'s average monthly return?
- Stoke Therapeutics Inc. (STOK) has averaged about 1.94% per month, positive in roughly 46% of months. The best month was Mar 2024 (+74.4%) and the worst was Nov 2022 (-49.2%).
More on Stoke Therapeutics Inc.
By month for: S&P 500 · S&P 500 Equal Weight · US Stock Market · Nasdaq-100